Breethe

United States
Rosedale, Indiana, United States, 21201

Company profile

Breethe company profile

Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems. Breethe's system, called the OXY-1 System, is designed to remove carbon dioxide and add oxygen to a patient's blood, much like a working human lung would. The tech eliminates the need for bulky oxygen tanks and allows patients in need of ECMO therapy to move around more easily. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Business identity

Phone number
410-328-3822
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
21201
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
6
Total equity funding
$18.4M
Last funding
Series Unknown / $8M / 2019-07-09
Last equity funding
Series Unknown / $8M
Founders
1
Articles
5
Exited on
2020-04-29

Founders and investors

Founders

Bartley P. Griffith